The analysis of the long-term impact of SARS-CoV-2 on the cellular immune system in individuals recovering from COVID-19 reveals a profound NKT cell impairment
preprint
OA: closed
Abstract
ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects millions of people and killed hundred-thousands of individuals. While acute and intermediate interactions between SARS-CoV-2 and the immune system have been studied extensively, long-term impacts on the cellular immune system remained to be analyzed. Here, we comprehensively characterized immunological changes in peripheral blood mononuclear cells in 49 COVID-19 convalescent individuals (CI) in comparison to 27 matched SARS-CoV-2 unexposed individuals (UI). Despite recovery from the disease for more than 2 months, CI showed significant decreases in frequencies of invariant NKT and NKT-like cells compared to UI. Concomitant with the decrease in NKT-like cells, an increase in the percentage of Annexin V and 7-AAD double positive NKT-like cells was detected, suggesting that the reduction in NKT-like cells results from cell death months after recovery. Significant increases in regulatory T cell frequencies, TIM-3 expression on CD4 and CD8 T cells, as well as PD-L1 expression on B cells were also observed in CI, while the cytotoxic potential of T cells and NKT-like cells, defined by GzmB expression, was significantly diminished. However, both CD4 and CD8 T cells of CI showed increased Ki67 expression and were fully capable to proliferate and produce effector cytokines upon TCR stimulation. Collectively, we provide the first comprehensive characterization of immune signatures in patients recovering from SARS-CoV-2 infection, suggesting that the cellular immune system of COVID-19 patients is still under a sustained influence even months after the recovery from disease.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (36)
- Single-cell landscape of immunological responses in COVID-19 patients via crossref
- doi:10.1056/nejmoa2002032 via crossref
- doi:10.1056/nejmc2011400 via crossref
- doi:10.1016/j.jns.2020.116832 via crossref
- doi:10.1016/s0140-6736(20)30183-5 via crossref
- doi:10.1016/s0140-6736(20)30154-9 via crossref
- doi:10.1016/s2213-2600(20)30079-5 via crossref
- doi:10.1016/j.immuni.2020.05.002 via crossref
- doi:10.1016/j.ebiom.2020.102763 via crossref
- doi:10.1001/jama.2020.1585 via crossref
- doi:10.1016/s0140-6736(20)30628-0 via crossref
- doi:10.1126/science.abb8925 via crossref
- doi:10.4049/jimmunol.1301262 via crossref
- doi:10.3389/fimmu.2018.00219 via crossref
- doi:10.1038/s41423-020-0401-3 via crossref
- doi:10.3389/fimmu.2020.00827 via crossref
- doi:10.1038/s41586-019-1326-9 via crossref
- doi:10.1038/s41586-019-1325-x via crossref
- doi:10.1038/s41591-020-0965-6 via crossref
- doi:10.1182/blood-2009-03-208736 via crossref
- doi:10.1371/journal.ppat.1006776 via crossref
- doi:10.1093/nsr/nwaa041 via crossref
- doi:10.3389/fimmu.2015.00255 via crossref
- doi:10.1038/ni.1841 via crossref
- doi:10.3389/fimmu.2016.00617 via crossref
- doi:10.1038/nri1309 via crossref
- doi:10.3390/ijms19020440 via crossref
- doi:10.1093/rheumatology/keq457 via crossref
- doi:10.1128/jvi.75.22.10746-10754.2001 via crossref
- doi:10.1128/jvi.76.15.7528-7534.2002 via crossref
- doi:10.4049/jimmunol.168.3.1490 via crossref
- doi:10.1128/jvi.77.3.2251-2257.2003 via crossref
- doi:10.1002/eji.200425495 via crossref
- doi:10.3390/cells9081750 via crossref
- doi:10.1016/j.ebiom.2020.102885 via crossref
- doi:10.1002/eji.200738120 via crossref
Source provenance
- crossref
- last seen: 2026-07-12T06:46:05.242975+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-07-31T06:42:51.797318+00:00